Objective During gestation and birth, problems are encountered in up to 15% of all births. Most problems are related to fetal hypoxia and preterm birth. It is estimated that every year over 30.000 babies in Europe suffer from birth asphyxia, despite the common use of monitoring. Recent Norwegian research (2013) revealed inadequate fetal monitoring is responsible for 50% of the cases where human error caused birth asphyxia (oxygen deficiency). It can be concluded that current monitoring technology does not detect vital information on fetal wellbeing, causing unnecessary risks which can eventually lead to fetal mortality. There is thus a clear market need for fetal monitoring technology that is accurate, safe (non-invasive) and easy to use. Nemo Healthcare, a high-tech startup company, is responding to this market need through the development of an innovative electrode patch and hardware/software module that can simultaneously record uterine activity and fetal heart rate. The solution of Nemo is characterized by unique and smart algorithms that can accurately and real-time filter contractions and the fetal heart rate from unprocessed abdominal electrophysiological signals, successfully eliminating noise or interference. The solution will be able to transfer the recorded data wirelessly. The solution will create a breakthrough in the field of fetal monitoring: it will result in better diagnoses, improved quality of care, a reduced number of birth-related problems, increased user friendliness (for medical staff as well as the patient) and lower healthcare cost (through remote monitoring, reduced treatment and avoidance of unnecessary surgery). Fields of science natural sciencescomputer and information sciencessoftwaresocial sciencessociologydemographymortalitymedical and health sciencesclinical medicinesurgerynatural sciencesmathematicspure mathematicstopologyengineering and technologyelectrical engineering, electronic engineering, information engineeringelectronic engineeringsensors Programme(s) H2020-EU.3.1. - SOCIETAL CHALLENGES - Health, demographic change and well-being Main Programme H2020-EU.2.1.3. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Advanced materials H2020-EU.3.1.3. - Treating and managing disease Topic(s) PHC-12-2015 - Clinical research for the validation of biomarkers and/or diagnostic medical devices Call for proposal H2020-SMEInst-2014-2015 See other projects for this call Sub call H2020-SMEINST-2-2015 Funding Scheme SME-2 - SME instrument phase 2 Coordinator NEMO HEALTHCARE BV Net EU contribution € 4 054 000,00 Address DE RUN 4630 5504 DB Veldhoven Netherlands See on map SME The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed. Yes Region Zuid-Nederland Noord-Brabant Zuidoost-Noord-Brabant Activity type Private for-profit entities (excluding Higher or Secondary Education Establishments) Links Contact the organisation Opens in new window Participation in EU R&I programmes Opens in new window HORIZON collaboration network Opens in new window Total cost € 4 054 000,00
